These NF-κB inhibitors primarily exert their cytotoxic effects through inducing G2/M cell cycle arrest and inhibiting DNA repair pathways, thereby sensitizing tumor cells to radiation and reducing cell proliferation (76–78, 80). The gene discussed is NFKB1; the disease is neoplasm.